These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5793035)

  • 1. Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital.
    Szeberenyi S; Tacconi MT; Garattini S
    Endocrinology; 1969 Sep; 85(3):575-6. PubMed ID: 5793035
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption and conjugation of metyrapone during diphenylhydantoin therapy: mechanism of the abnormal response to oral metyrapone.
    Jubiz W; Levinson RA; Meikle AW; West CD; Tyler FH
    Endocrinology; 1970 Feb; 86(2):328-31. PubMed ID: 4311903
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.
    Meikle AW; Jubiz W; Matsukura S; West CD; Tyler FH
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1553-8. PubMed ID: 4310497
    [No Abstract]   [Full Text] [Related]  

  • 4. Dilantin and metyrapone: a clinically significant example of enzyme induction.
    Tyler FH; West CD; Jubiz W; Meikle AW
    Trans Am Clin Climatol Assoc; 1970; 81():213-9. PubMed ID: 4330036
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
    Werk EE; Thrasher K; Choi Y; Sholiton LJ
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1358-60. PubMed ID: 4292251
    [No Abstract]   [Full Text] [Related]  

  • 6. Removal of plasma metyrapone in rats submitted to previous pharmacological treatment.
    Szeberenyi S; Szalay KS; Garattini S
    J Pharm Pharmacol; 1969 Mar; 21(3):201-2. PubMed ID: 4388221
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation of two metyrapone N-oxides by rat liver microsomes.
    De Graeve J; Gielen JE; Kahl GF; Tüttenberg KH; Kahl R; Maume B
    Drug Metab Dispos; 1979; 7(3):166-70. PubMed ID: 38088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Evidence for oxidative metabolism of metyrapone in rat liver microsomes.
    Kahl R; Tüttenberg KH; Niedermeier F; Kahl GF
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R44. PubMed ID: 4152363
    [No Abstract]   [Full Text] [Related]  

  • 9. Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations.
    Kutt H; Fouts JR
    J Pharmacol Exp Ther; 1971 Jan; 176(1):11-26. PubMed ID: 5569630
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum beta-glucuronidase activity in patients treated with phenobarbital and diphenylhydantoin].
    Tutor JC; Fernández MP; Paz JM
    Arch Farmacol Toxicol; 1982 Apr; 8(1):37-44. PubMed ID: 7138085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthetic steroids that inhibit the intensified biotransformation of steroid hormones caused by the prolonged administration of phenobarbital to animals].
    Nedel'kina SV; Argutinskaia SV; Kusmartseva LP; Kamernitskiĭ AV; Turuta AM
    Vopr Med Khim; 1974; 20(2):142-8. PubMed ID: 4450512
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug interactions. 3. Therapeutic implications of enzyme induction.
    Soyka LF
    Pediatrics; 1972 Sep; 50(3):489-90. PubMed ID: 5056430
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of liver microsomal cortisol 6beta-hydroxylase by diphenylhydantoin or phenobarbital: an explanation for the increased excretion of 6-hydroxycortisol in humans treated with these drugs.
    Conney AH; Jacobson M; Schneidman K; Kuntzman R
    Life Sci; 1965 May; 4(10):1091-8. PubMed ID: 5838511
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on microsomal hydroxylation of naphthalene].
    Netter KJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(3):375-87. PubMed ID: 4238723
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spectral properties of cytochrome P450 following induction with phenobarbital, benzopyrene and methylcholanthrene].
    Remmer H; Greim G; Hildebrandt A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):189-90. PubMed ID: 4239220
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the activation of dopa decarboxylase and other cytoplasmic liver enzymes by inducers of microsomal enzymes].
    Palm D; Ernzerhoff C; Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(4):352-71. PubMed ID: 4174080
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased deiodination of L-thyroxine and L-triiodothyronine by liver microsomes from rats treated with phenobarbital.
    Schwartz HL; Kozyreff V; Surks MI; Oppenheimer JH
    Nature; 1969 Mar; 221(5187):1262-3. PubMed ID: 5773848
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcium metabolism disorders in antiepileptic therapy].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 May; 98(20):1043-6. PubMed ID: 4350570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Activation of liver dopa decarboxylase by inducers of microsomal enzymes].
    Ernzerhoff C; Holtz P; Palm D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):14-5. PubMed ID: 4172902
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of metyrapone by a soluble enzyme system in rat liver.
    Dünges W; Kahl GF
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(3):293-6. PubMed ID: 4394454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.